SYDNEY: The rules which prevent drug companies promoting their
products directly to consumers are set to be relaxed under
recommendations from a review of the laws. The review, commissioned by
the Committee of Australian Governments, has attracted intense lobbying
from both the pharmaceutical industry, which wants the rules relaxed,
and consumer groups, who want the tight rules to stay. ’We do want
information to be much more available to consumers about medicine,’ said
chair of the review, Rhonda Galbally.